Published in Protein Sci on June 01, 1999
Estimating hydration changes upon biomolecular reactions from osmotic stress, high pressure, and preferential hydration experiments. Proc Natl Acad Sci U S A (2004) 1.44
Partial molar volume, surface area, and hydration changes for equilibrium unfolding and formation of aggregation transition state: high-pressure and cosolute studies on recombinant human IFN-gamma. Proc Natl Acad Sci U S A (2001) 1.01
Probing the role of water in protein conformation and function. Philos Trans R Soc Lond B Biol Sci (2004) 0.86
Temperature and osmotic stress dependence of the thermodynamics for binding linker histone H1(0), Its carboxyl domain (H1(0)-C) or globular domain (H1(0)-G) to B-DNA. Biochem Biophys Rep (2017) 0.75
Crystal structure of trp repressor/operator complex at atomic resolution. Nature (1988) 7.34
The control of protein stability and association by weak interactions with water: how do solvents affect these processes? Annu Rev Biophys Biomol Struct (1993) 4.36
Nucleotide sequence and expression of Escherichia coli trpR, the structural gene for the trp aporepressor. Proc Natl Acad Sci U S A (1980) 4.35
Protein solvation in allosteric regulation: a water effect on hemoglobin. Science (1992) 3.60
Macromolecules and water: probing with osmotic stress. Methods Enzymol (1995) 3.30
The three-dimensional structure of trp repressor. Nature (1985) 3.26
On the specificity of DNA-protein interactions. Proc Natl Acad Sci U S A (1986) 3.11
The stabilization of proteins by osmolytes. Biophys J (1985) 3.11
Purification and characterization of trp aporepressor. Proc Natl Acad Sci U S A (1983) 2.70
Tandem binding in crystals of a trp repressor/operator half-site complex. Nature (1993) 2.65
Structure and regulation of aroH, the structural gene for the tryptophan-repressible 3-deoxy-D-arabino-heptulosonic acid-7-phosphate synthetase of Escherichia coli. J Mol Biol (1981) 2.62
Mutational studies with the trp repressor of Escherichia coli support the helix-turn-helix model of repressor recognition of operator DNA. Proc Natl Acad Sci U S A (1985) 2.48
Determinants of repressor/operator recognition from the structure of the trp operator binding site. Nature (1994) 2.22
Interaction of the operator of the tryptophan operon with repressor. Proc Natl Acad Sci U S A (1974) 2.02
Measured change in protein solvation with substrate binding and turnover. Biochemistry (1993) 1.82
Chemical potential measurements of deoxyhemoglobin S polymerization. Determination of the phase diagram of an assembling protein. J Mol Biol (1985) 1.75
Probing protein hydration and conformational states in solution. Biophys J (1997) 1.74
Analysis of binding in macromolecular complexes: a generalized numerical approach. Anal Biochem (1990) 1.70
Fluorescence anisotropy assays implicate protein-protein interactions in regulating trp repressor DNA binding. Biochemistry (1993) 1.66
Water release associated with specific binding of gal repressor. EMBO J (1995) 1.53
DNA specificity determinants of Escherichia coli tryptophan repressor binding. Genes Dev (1987) 1.49
Molecular recognition mediated by bound water. A mechanism for star activity of the restriction endonuclease EcoRI. J Mol Biol (1993) 1.43
Numerical analysis of binding data: advantages, practical aspects, and implications. Methods Enzymol (1992) 1.42
Hydrostatic and osmotic pressure as tools to study macromolecular recognition. Methods Enzymol (1995) 1.28
The role of water in protein-DNA interactions. Curr Opin Struct Biol (1997) 1.28
In disperse solution, "osmotic stress" is a restricted case of preferential interactions. Proc Natl Acad Sci U S A (1998) 1.26
A nontraditional role for water in the cytochrome c oxidase reaction. Biochemistry (1990) 1.25
Improvements in the numerical analysis of thermodynamic data from biomolecular complexes. Anal Biochem (1993) 1.22
Hydrostatic pressure reverses osmotic pressure effects on the specificity of EcoRI-DNA interactions. Biochemistry (1994) 1.21
Mutagenesis supports water mediated recognition in the trp repressor-operator system. EMBO J (1994) 1.18
Water-mediated protein-DNA interactions: the relationship of thermodynamics to structural detail. Protein Sci (1996) 1.13
Changes in solvation during DNA binding and cleavage are critical to altered specificity of the EcoRI endonuclease. Proc Natl Acad Sci U S A (1998) 1.13
Heterogeneity in molecular recognition by restriction endonucleases: osmotic and hydrostatic pressure effects on BamHI, Pvu II, and EcoRV specificity. Proc Natl Acad Sci U S A (1995) 1.08
Probing the physical basis for trp repressor-operator recognition. J Mol Biol (1999) 1.07
How does trp repressor bind to its operator? J Biol Chem (1991) 1.06
Role of protein--protein interactions in the regulation of transcription by trp repressor investigated by fluorescence spectroscopy. Biochemistry (1992) 1.05
The solution structures of the trp repressor-operator DNA complex. J Mol Biol (1994) 0.99
In vivo and in vitro studies of TrpR-DNA interactions. J Mol Biol (1996) 0.98
The DNA target of the trp repressor. EMBO J (1992) 0.96
Role of macromolecular hydration in the binding of the Escherichia coli cyclic AMP receptor to DNA. Biochemistry (1997) 0.95
Affinity and specificity of trp repressor-DNA interactions studied with fluorescent oligonucleotides. J Mol Biol (1997) 0.91
Dependence of trp repressor-operator affinity, stoichiometry, and apparent cooperativity on DNA sequence and size. J Biol Chem (1993) 0.89
Participation of water in Hin recombinase--DNA recognition. Protein Sci (1996) 0.89
Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol (2001) 5.25
Tumors secreting human TNF/cachectin induce cachexia in mice. Cell (1987) 4.19
The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol (2000) 3.69
First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin. Ann Oncol (2002) 2.87
Activation-induced cell death in T cell hybridomas is due to apoptosis. Morphologic aspects and DNA fragmentation. J Immunol (1990) 2.26
CTX-M-1, CTX-M-3, and CTX-M-14 beta-lactamases from Enterobacteriaceae isolated in France. Antimicrob Agents Chemother (2002) 2.09
Implicit learning: news from the front. Trends Cogn Sci (1998) 2.07
Identification of group B streptococcal Sip protein, which elicits cross-protective immunity. Infect Immun (2000) 1.73
Fluorescence anisotropy assays implicate protein-protein interactions in regulating trp repressor DNA binding. Biochemistry (1993) 1.66
Optimizing the erythromycin breath test for use in cancer patients. Clin Cancer Res (2000) 1.60
Capecitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma. Eur J Cancer (2001) 1.52
Pressure provides new insights into protein folding, dynamics and structure. Trends Biochem Sci (2001) 1.49
Evidence for a molten globule-like transition state in protein folding from determination of activation volumes. Biochemistry (1995) 1.46
Probing the contribution of internal cavities to the volume change of protein unfolding under pressure. Protein Sci (1998) 1.27
Exploring the temperature-pressure phase diagram of staphylococcal nuclease. Biochemistry (1999) 1.27
Frequency and diversity of Class A extended-spectrum beta-lactamases in hospitals of the Auvergne, France: a 2 year prospective study. J Antimicrob Chemother (2004) 1.26
The human estrogen receptor alpha dimer binds a single SRC-1 coactivator molecule with an affinity dictated by agonist structure. J Mol Biol (2001) 1.10
Anti-actin antibodies. Chemical modification allows the selective production of antibodies to the N-terminal region. J Immunol Methods (1986) 1.09
Probing the physical basis for trp repressor-operator recognition. J Mol Biol (1999) 1.07
Fluorescence approaches to study of protein-nucleic acid complexation. Methods Enzymol (1997) 1.05
Structural variations in actins. A study of the immunological reactivity of the N-terminal region. Biochem J (1986) 1.05
Testing the correlation between delta A and delta V of protein unfolding using m value mutants of staphylococcal nuclease. Biochemistry (1996) 1.04
DNAse I-actin complex: an immunological study. Biosci Rep (1985) 1.02
Equilibrium binding of estrogen receptor with DNA using fluorescence anisotropy. J Biol Chem (1997) 1.02
Cross-linking of the skeletal myosin subfragment 1 heavy chain to the N-terminal actin segment of residues 40-113. Biochemistry (1988) 1.02
Anti-actin antibodies. An immunological approach to the myosin-actin and the tropomyosin-actin interfaces. Biochem J (1987) 1.02
High-pressure denaturation of staphylococcal nuclease proline-to-glycine substitution mutants. Biochemistry (1996) 1.02
Pressure-jump small-angle x-ray scattering detected kinetics of staphylococcal nuclease folding. Biophys J (2001) 1.02
Long-term outcome of radiological-guided insertion of implanted central venous access port devices (CVAPD) for the delivery of chemotherapy in cancer patients: institutional experience and review of the literature. Br J Cancer (2004) 1.02
Volume, expansivity and isothermal compressibility changes associated with temperature and pressure unfolding of Staphylococcal nuclease. J Mol Biol (2001) 1.01
Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide. Br J Cancer (2006) 1.01
Antigenic probes locate the myosin subfragment 1 interaction site on the N-terminal part of actin. Biosci Rep (1986) 0.96
Effect of intramuscular injections on serum creatine phosphokinase activity. Am J Med Sci (1970) 0.96
Conformational changes induced by Mg2+ on actin monomers. An immunologic attempt to localize the affected region. FEBS Lett (1985) 0.96
Localization of a new alpha-actinin binding site in the COOH-terminal part of actin sequence. Biochem Biophys Res Commun (1990) 0.96
Dissociation of the lactose repressor protein tetramer using high hydrostatic pressure. Biochemistry (1986) 0.95
The kinetic basis for the stabilization of staphylococcal nuclease by xylose. Protein Sci (1997) 0.95
Quantitative characterization of the interaction between purified human estrogen receptor alpha and DNA using fluorescence anisotropy. Nucleic Acids Res (2000) 0.94
Determination of the volume changes for pressure-induced transitions of apomyoglobin between the native, molten globule, and unfolded states. Biophys J (1998) 0.94
Induction by chemically modified actin derivatives of antibody specificity. A relation between modified sites and antibody interactions with monomeric and filamentous actins. FEBS Lett (1983) 0.94
Localization and identification of actin structures involved in the filamin-actin interaction. Eur J Biochem (1992) 0.94
Hydroxychloroquine for the treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant (2000) 0.93
Tryptophan replacements in the trp aporepressor from Escherichia coli: probing the equilibrium and kinetic folding models. Protein Sci (1993) 0.93
Fine specificity of antigen recognition by T cell hybridoma clones specific for poly-18: a synthetic polypeptide antigen of defined sequence and conformation. J Immunol (1985) 0.92
Affinity and specificity of trp repressor-DNA interactions studied with fluorescent oligonucleotides. J Mol Biol (1997) 0.91
Domestic violence associated with anabolic steroid abuse. Am J Psychiatry (1993) 0.90
Pressure-jump studies of the folding/unfolding of trp repressor. J Mol Biol (1999) 0.90
Unfolding of trp repressor studied using fluorescence spectroscopic techniques. Biochemistry (1992) 0.90
Purification and characterization of an acetyl esterase from Aspergillus niger. Appl Biochem Biotechnol (1994) 0.89
Species differences in the response of amino acid transport to ouabain and a sodium-free medium. Comp Biochem Physiol (1966) 0.88
Visualization of trp repressor and its complexes with DNA by atomic force microscopy. Biophys J (1998) 0.88
Green fluorescent protein as a selectable marker of fibronectin-facilitated retroviral gene transfer in primary human T lymphocytes. Hum Gene Ther (1999) 0.88
Hickman catheter tip displacement. South Med J (1985) 0.87
Definitive radiotherapy or chemoradiotherapy in the treatment of Merkel cell carcinoma. Clin Oncol (R Coll Radiol) (2012) 0.86
Isolation and structural properties of a high-molecular-weight actin-binding protein (filamin-like protein) in hog thyroid gland. Eur J Biochem (1982) 0.86
Beryllium metal solubility in the lung, comparison of metal and hot-pressed forms by in vivo and in vitro dissolution bioassays. Hum Toxicol (1987) 0.86
Mechanism of protein binding to spherical polyelectrolyte brushes studied in situ using two-photon excitation fluorescence fluctuation spectroscopy. Phys Rev E Stat Nonlin Soft Matter Phys (2004) 0.85
Probing pH and pressure effects on the apomyoglobin heme pocket with the 2'-(N,N-dimethylamino)-6-naphthoyl-4-trans-cyclohexanoic acid fluorophore. Biophys J (1996) 0.85
Structural variations in actins. Biochemical and immunological tools for probing the structure of rabbit skeletal-muscle and bovine aortic actins. Biochem J (1985) 0.85
A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell lung cancer. Ann Oncol (2006) 0.84
Characterization of the folding and unfolding reactions of a small beta-barrel protein of novel topology, the MTCP1 oncogene product P13. J Mol Biol (2001) 0.84
[Oxcarbazepine and DRESS syndrome: a paediatric cause of acute liver failure]. Arch Pediatr (2004) 0.84
HIV-1 Nef protein: purification, crystallizations, and preliminary X-ray diffraction studies. Protein Sci (1997) 0.84
No improvement in lung cancer care: the management of lung cancer in 1996 and 2002 in New South Wales. Intern Med J (2008) 0.83
Identification of actin and HSP 70 as cyclosporin A binding proteins by photoaffinity labeling and fluorescence displacement assays. J Biol Chem (1992) 0.83
[Severe hypoglycemia induced by tramadol: two new cases of an unlisted side effect]. Rev Med Interne (2011) 0.83
Evidence for coupling of folding and function in trp repressor: physical characterization of the superrepressor mutant AV77. J Mol Biol (1995) 0.83
Lung dissolution of uranium tetrafluoride in rats and baboons. Comparison with dissolution by alveolar macrophages in culture and chemical dissolution. Hum Toxicol (1989) 0.83
The basis for the super-repressor phenotypes of the AV77 and EK18 mutants of trp repressor. J Mol Biol (2000) 0.83
Patient-controlled analgesia for severe cancer pain. Arch Intern Med (1986) 0.83
High-pressure fluorescence methods for observing subunit dissociation in hemoglobin. Methods Enzymol (1994) 0.81
MyoD-E12 heterodimers and MyoD-MyoD homodimers are equally stable. Biochemistry (1997) 0.81
The distribution of tetanus in Argentina. Bull Pan Am Health Organ (1981) 0.81
Randomized cross-over trial comparing inpatient and outpatient administration of high-dose cisplatin. Intern Med J (2011) 0.80
New strategies in allogeneic stem cell transplantation: immunotherapy using irradiated allogeneic T cells. Bone Marrow Transplant (2000) 0.80
Irofulven as first line therapy in recurrent or metastatic gastric cancer: a phase II multicenter study by the Cancer Therapeutics Research Group (CTRG). Cancer Chemother Pharmacol (2006) 0.80
New catheter for endovascular interventional procedures. Radiology (1987) 0.80
Characterization of charge change super-repressor mutants of trp repressor: effects on oligomerization conformation, ligation and stability. J Mol Biol (1996) 0.80
Unusual presentations of germ cell tumors. Case 2. Seminoma of the conus medullaris. J Clin Oncol (2001) 0.80
Localization of a myosin subfragment-1 interaction site on the C-terminal part of actin. Biochem J (1992) 0.79
Nonviral in vivo gene therapy for tissue engineering of articular cartilage and tendon repair. Clin Orthop Relat Res (2000) 0.79
When is a cancer treatment worthwhile? N Engl J Med (1990) 0.79
Highly sensitive analysis of the antifolate pemetrexed sodium, a new cancer agent, in human plasma and urine by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl (2001) 0.79
A phase II trial of paclitaxel and epirubicin in advanced breast cancer. Br J Cancer (2000) 0.78
Effect of ligand and DNA binding on the interaction between human transcription intermediary factor 1alpha and estrogen receptors. Mol Endocrinol (1999) 0.78
Subunit interactions in hemoglobin probed by fluorescence and high-pressure techniques. Biochemistry (1990) 0.78
Electrostatic forces contribute to interactions between trp repressor dimers. Biophys J (1994) 0.78
[Procedure used to follow-up a cohort of IVF children. Interests and limits of tools performed to longitudinal follow up for a monocentric cohort]. Rev Epidemiol Sante Publique (2011) 0.78
Localization of two myosin-subfragment-1 binding contacts in the 96-132 region of actin subdomain-1. Eur J Biochem (1993) 0.78
Dacomitinib versus erlotinib in patients with EGFR-mutated advanced nonsmall-cell lung cancer (NSCLC): pooled subset analyses from two randomized trials. Ann Oncol (2016) 0.78
The PREGVAXGRIP study: a cohort study to assess foetal and neonatal consequences of in utero exposure to vaccination against A(H1N1)v2009 influenza. Drug Saf (2013) 0.78
[Non invasive evaluation of the embryo: morphology of preimplantation embryos]. Gynecol Obstet Fertil (2009) 0.78
Oligomerization of the EK18 mutant of the trp repressor of Escherichia coli as observed by NMR spectroscopy. Arch Biochem Biophys (1999) 0.77
[Pneumococcus observatory data in the Rhône-Alps region. Results from 1996]. Pathol Biol (Paris) (1999) 0.77
Retrovirus-mediated transduction of primary ZAP-70-deficient human T cells results in the selective growth advantage of gene-corrected cells: implications for gene therapy. Gene Ther (2000) 0.77